Table 3.
Contents of TNF-α, IL-1β, VEGF, and HIF-1α.
| Outcome measures | Treatment group (n = 20) | Control group (n = 17) | P value |
|---|---|---|---|
| TNF-α (pg/mL), mean (SD) | |||
| Baseline | 30.23 (15.08) | 32.27 (16.51) | 0.70 |
| Posttherapy | 21.53 (13.70) | 30.90 (14.14) | 0.049 |
| IL-1β (pg/mL), mean (SD) | |||
| Baseline | 30.16 (15.65) | 36.01 (14.87) | 0.25 |
| Posttherapy | 20.53 (12.88) | 30.28 (13.81) | 0.033 |
| VEGF (pg/mL), mean (SD) | |||
| Baseline | 106.92 (50.69) | 126.43 (55.77) | 0.273 |
| Posttherapy | 65.51 (32.82) | 93.36 (45.42) | 0.038 |
| HIF-1α (pg/mL), mean (SD) | |||
| Baseline | 32.92 (18.46) | 36.13 (18.60) | 0.60 |
| Posttherapy | 22.77 (13.10) | 33.29 (17.11) | 0.048 |
P value by independent samples t-test.